Friday, November 6, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

Barrick Gold Exits Canadian Operations with Major Mine Divestiture

Robert Sasse by Robert Sasse
September 15, 2025
in Commodities, Gold & Precious Metals, Mergers & Acquisitions
0
Barrick Gold Stock
0
SHARES
183
VIEWS
Share on FacebookShare on Twitter

Barrick Gold has initiated a significant strategic pivot, announcing the sale of its Hemlo mine in Ontario for a total potential consideration of $1.09 billion. This transaction effectively concludes the Canadian mining giant’s era as a domestic operator within its home country.

The company has entered into a definitive agreement to divest the asset to Carcetti Capital Corp., which will be renamed Hemlo Mining Corp. upon the deal’s closure. This move is a direct execution of Barrick’s stated strategy to concentrate its portfolio on world-class “Tier One” gold and copper holdings.

Transaction Structure and Strategic Rationale

The financial terms of the sale are structured to provide both immediate and future value for Barrick. The package includes:
* An upfront cash payment of $875 million payable at closing
* An additional $50 million in shares of the newly renamed acquiring company
* Contingent payments of up to $165 million, which are linked to the mine’s future gold production and the performance of gold prices

Barrick’s President and CEO, Mark Bristow, characterized the sale as the closing of a long chapter for the company, noting it was achieved at an attractive valuation. The Hemlo operation has been in continuous production for over three decades. In 2024, it yielded 143,000 ounces of gold, accounting for approximately 3.5% of Barrick’s total output.

Capital Allocation and Portfolio Streamlining

Should investors sell immediately? Or is it worth buying Barrick Gold?

Proceeds from the divestiture are earmarked to further fortify Barrick’s balance sheet and will support its capital allocation framework, a key component of which is returning value to shareholders. This sale is the latest in a series of disciplined moves to divest non-core assets.

When combined with the earlier dispositions of its interests in the Donlin and Alturas projects, Barrick’s gross proceeds from such non-core sales are projected to surpass $2 billion by 2025.

Future Direction: A Shift in Geographic Focus

With the sale of its last remaining operated mine in Canada, Barrick is poised to sharpen its focus on large-scale international growth projects. This strategic direction is expected to include a heightened emphasis on major copper developments, such as the massive Reko Diq project in Pakistan.

This trajectory aligns with the corporation’s long-term vision to significantly boost its production in gold equivalent ounces by the end of this decade. Market observers will now monitor for the successful completion of the Hemlo transaction, anticipated in the fourth quarter, and any subsequent announcements regarding the deployment of the newly raised capital.

Ad

Barrick Gold Stock: Buy or Sell?! New Barrick Gold Analysis from November 5 delivers the answer:

The latest Barrick Gold figures speak for themselves: Urgent action needed for Barrick Gold investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 5.

Barrick Gold: Buy or sell? Read more here...

Tags: Barrick Gold
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Shell Stock
Commodities

Shell’s Gas Ambitions Meet Buyback Discipline as LNG Canada Talks Take Shape

September 25, 2026
Commerzbank Stock
Banking & Insurance

Commerzbank’s CEO Puts a Price on Her Future as UniCredit Circles Closer

September 7, 2026
Almonty Stock
Asian Markets

Almonty’s Double Play: A $300 Million Buyback Lands as Sangdong’s Stockpile Grows

September 7, 2026
Next Post
Super Micro Computer Stock

Super Micro Stock Surges on Key AI Chip Deployment Milestone

Anglo American Stock

Anglo American and Teck Forge Landmark Partnership to Reshape Critical Minerals Sector

Intellia Therapeutics Stock

A Turning Point for Intellia Therapeutics: Clinical Progress and Investor Confidence Build Momentum

Recommended

indiemiconductor Stock

Indie Semiconductor Shares Face Technical Headwinds

1 year ago
BioNTech Stock

BioNTech Secures CureVac Acquisition in Landmark mRNA Deal

11 months ago
Food Retailers Market Capitalization

Victorias Secret Reports Strong Earnings Growth and Strategic Initiatives for Future Success

3 years ago

CNH Industrials Financial Report for Q4 2023 Meeting Expectations and Predicting a Slowdown in 2024

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

Pharma Pays for the Rotation While Crypto Hunts for a Floor

Tech Loses $1 Trillion, but the Rest of the Market Holds

Alphabet’s Cloud Doubles, Its Cash Turns Negative, the Stock Sinks

Margins Over Stories: Who Delivers Before the Fed and Big Tech

UPS and Coca-Cola Raise Guidance by Charging More, Not Selling More

Trending

Fastly Stock
Newsletter

Maersk Lifts Guidance a Third Time, and the Stock Still Sinks

by Stephanie Dugan
November 5, 2026
0

Dear readers, Raised guidance was supposed to be the safe harbor of earnings season. Maersk has tested...

AMD Stock

Democrats Win, and the Market Sorts Solar From Musk and Defense

November 4, 2026
Apple Stock

Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

November 3, 2026
Lumentum Stock

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

November 2, 2026
Bitcoin Stock

Pharma Pays for the Rotation While Crypto Hunts for a Floor

October 31, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Maersk Lifts Guidance a Third Time, and the Stock Still Sinks
  • Democrats Win, and the Market Sorts Solar From Musk and Defense
  • Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com